Skip to main content
Erschienen in: Die Ophthalmologie 11/2023

17.10.2023 | Glaukom | Leitthema

Bewusstsein für eine Glaukomerkrankung in der Bevölkerung

verfasst von: Dr. med. Julia V. Stingl, R. Greslechner, Caroline Brandl, Iris M. Heid, Esther M. Hoffmann, Norbert Pfeiffer, Alexander K. Schuster

Erschienen in: Die Ophthalmologie | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Zusammenfassung

Hintergrund

Glaukomerkrankungen sind keine seltene Entität. Weil jedoch kaum Symptome auftreten und die Gesichtsfelddefekte häufig erst spät bemerkt werden, bleibt ein großer Anteil der Glaukomerkrankungen unerkannt. Ziel der Arbeit war es, den Anteil nicht diagnostizierter Glaukomerkrankungen in deutschen populationsbasierten Studien zu ermitteln und sie in den Literaturkontext einzuordnen.

Material und Methoden

Im Rahmen der Gutenberg-Gesundheitsstudie (GHS) und der Altersbezogenen Untersuchungen zur Gesundheit der Universität Regensburg (AugUR) wurden die Glaukomprävalenz anhand von Gesichtsfelduntersuchungen und Fundusfarbfotos mithilfe der Kriterien der International Society of Geographical and Epidemiological Ophthalmology (ISGEO) sowie die selbstberichteten Glaukomerkrankungen erhoben, und der Anteil nicht diagnostizierter Glaukome wurde bestimmt.

Ergebnisse

In der GHS betrug der Anteil nicht diagnostizierter Glaukome 55 %, in der AugUR-Studie 53 %. Die Ergebnisse passen zu Daten aus anderen Ländern, in denen der Anteil nicht erkannter Glaukome zwischen 33 % und 78 % liegt. In GHS und AugUR war der Anteil nicht diagnostizierter Glaukome in jüngeren Altersgruppen und bei Frauen höher.

Diskussion

Etwa jede zweite Glaukomerkrankung in Deutschland ist unentdeckt. Da die Symptome oft unspezifisch sind oder lange ausbleiben, besteht durch das fehlende Bewusstsein für Glaukomerkrankungen die Gefahr für einen fortschreitenden Gesichtsfelddefekt und Erblindung. Studien zeigen, dass ein systematisches Screening dieses Risiko halbieren kann.
Literatur
1.
Zurück zum Zitat Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121(11):2081–2090 PubMed Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121(11):2081–2090 PubMed
2.
Zurück zum Zitat Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR (2016) Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol 100(1):86–93 PubMed Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR (2016) Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol 100(1):86–93 PubMed
3.
Zurück zum Zitat GBD 2019 Blindness and Vision Impairment Collaborators (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health 9(2):e144–e60 GBD 2019 Blindness and Vision Impairment Collaborators (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health 9(2):e144–e60
4.
Zurück zum Zitat No authors listed (2000) The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.the AGIS investigators. Am J Ophthalmol 130(4):429–440 No authors listed (2000) The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.the AGIS investigators. Am J Ophthalmol 130(4):429–440
5.
Zurück zum Zitat No authors listed (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative normal-tension glaucoma study group. Am J Ophthalmol 126(4):498–505 No authors listed (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative normal-tension glaucoma study group. Am J Ophthalmol 126(4):498–505
6.
Zurück zum Zitat Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA et al (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108(11):1943–1953 PubMed Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA et al (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108(11):1943–1953 PubMed
7.
Zurück zum Zitat Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M (2002) Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 120(10):1268–1279 PubMed Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M (2002) Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 120(10):1268–1279 PubMed
8.
Zurück zum Zitat Shah YS, Cheng M, Mihailovic A, Fenwick E, Lamoureux E, Ramulu PY (2022) Patient-reported symptoms demonstrating an association with severity of visual field damage in glaucoma. Ophthalmology 129(4):388–396 PubMed Shah YS, Cheng M, Mihailovic A, Fenwick E, Lamoureux E, Ramulu PY (2022) Patient-reported symptoms demonstrating an association with severity of visual field damage in glaucoma. Ophthalmology 129(4):388–396 PubMed
9.
Zurück zum Zitat Crabb DP, Smith ND, Glen FC, Burton R, Garway-Heath DF (2013) How does glaucoma look?: patient perception of visual field loss. Ophthalmology 120(6):1120–1126 PubMed Crabb DP, Smith ND, Glen FC, Burton R, Garway-Heath DF (2013) How does glaucoma look?: patient perception of visual field loss. Ophthalmology 120(6):1120–1126 PubMed
10.
Zurück zum Zitat Fatehi N, Nowroozizadeh S, Henry S, Coleman AL, Caprioli J, Nouri-Mahdavi K (2017) Association of structural and functional measures with contrast sensitivity in glaucoma. Am J Ophthalmol 178:129–139 PubMedCentralPubMed Fatehi N, Nowroozizadeh S, Henry S, Coleman AL, Caprioli J, Nouri-Mahdavi K (2017) Association of structural and functional measures with contrast sensitivity in glaucoma. Am J Ophthalmol 178:129–139 PubMedCentralPubMed
11.
Zurück zum Zitat Amanullah S, Okudolo J, Rahmatnejad K, Lin SC, Wizov SS, Manzi Muhire RS et al (2017) The relationship between contrast sensitivity and retinal nerve fiber layer thickness in patients with glaucoma. Graefes Arch Clin Exp Ophthalmol 255(12):2415–2422 PubMed Amanullah S, Okudolo J, Rahmatnejad K, Lin SC, Wizov SS, Manzi Muhire RS et al (2017) The relationship between contrast sensitivity and retinal nerve fiber layer thickness in patients with glaucoma. Graefes Arch Clin Exp Ophthalmol 255(12):2415–2422 PubMed
12.
Zurück zum Zitat Owidzka M, Laudanska-Olszewska I, Omulecki W (2016) Contrast sensitivity assessment in primary open angle glaucoma and ocular hypertension. Klin Oczna 118(1):7–10 PubMed Owidzka M, Laudanska-Olszewska I, Omulecki W (2016) Contrast sensitivity assessment in primary open angle glaucoma and ocular hypertension. Klin Oczna 118(1):7–10 PubMed
13.
Zurück zum Zitat Bierings R, de Boer MH, Jansonius NM (2018) Visual performance as a function of luminance in glaucoma: the de Vries-Rose, weber’s, and Ferry-Porter’s law. Invest Ophthalmol Vis Sci 59(8):3416–3423 PubMed Bierings R, de Boer MH, Jansonius NM (2018) Visual performance as a function of luminance in glaucoma: the de Vries-Rose, weber’s, and Ferry-Porter’s law. Invest Ophthalmol Vis Sci 59(8):3416–3423 PubMed
14.
Zurück zum Zitat Ouchi J, Kunikata H, Omodaka K, Sato H, Sato H, Ito A et al (2019) Color visual acuity in preperimetric glaucoma and open-angle glaucoma. PLoS ONE 14(4):e215290 PubMedCentralPubMed Ouchi J, Kunikata H, Omodaka K, Sato H, Sato H, Ito A et al (2019) Color visual acuity in preperimetric glaucoma and open-angle glaucoma. PLoS ONE 14(4):e215290 PubMedCentralPubMed
15.
Zurück zum Zitat Mansouri K, Orgül S, Meier-Gibbons F, Mermoud A (2006) Awareness about glaucoma and related eye health attitudes in Switzerland: a survey of the general public. Ophthalmologica 220(2):101–108 PubMed Mansouri K, Orgül S, Meier-Gibbons F, Mermoud A (2006) Awareness about glaucoma and related eye health attitudes in Switzerland: a survey of the general public. Ophthalmologica 220(2):101–108 PubMed
16.
Zurück zum Zitat Pfeiffer N, Krieglstein GK, Wellek S (2002) Knowledge about glaucoma in the unselected population: a German survey. J Glaucoma 11(5):458–463 PubMed Pfeiffer N, Krieglstein GK, Wellek S (2002) Knowledge about glaucoma in the unselected population: a German survey. J Glaucoma 11(5):458–463 PubMed
17.
Zurück zum Zitat Mitchell P, Smith W, Attebo K, Healey PR (1996) Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 103(10):1661–1669 PubMed Mitchell P, Smith W, Attebo K, Healey PR (1996) Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 103(10):1661–1669 PubMed
18.
Zurück zum Zitat Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT (1994) The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 101(11):1851–1855 PubMed Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT (1994) The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 101(11):1851–1855 PubMed
19.
Zurück zum Zitat McCann P, Hogg R, Wright DM, Pose-Bazarra S, Chakravarthy U, Peto T et al (2020) Glaucoma in the Northern Ireland cohort for the longitudinal study of ageing (NICOLA): cohort profile, prevalence, awareness and associations. Br J Ophthalmol 104(11):1492–1499 PubMed McCann P, Hogg R, Wright DM, Pose-Bazarra S, Chakravarthy U, Peto T et al (2020) Glaucoma in the Northern Ireland cohort for the longitudinal study of ageing (NICOLA): cohort profile, prevalence, awareness and associations. Br J Ophthalmol 104(11):1492–1499 PubMed
20.
Zurück zum Zitat Shaikh Y, Yu F, Coleman AL (2014) Burden of undetected and untreated glaucoma in the United States. Am J Ophthalmol 158(6):1121–1129.e1 PubMed Shaikh Y, Yu F, Coleman AL (2014) Burden of undetected and untreated glaucoma in the United States. Am J Ophthalmol 158(6):1121–1129.e1 PubMed
21.
Zurück zum Zitat Chua J, Baskaran M, Ong PG, Zheng Y, Wong TY, Aung T et al (2015) Prevalence, risk factors, and visual features of undiagnosed glaucoma: the Singapore epidemiology of eye diseases study. JAMA Ophthalmol 133(8):938–946 PubMed Chua J, Baskaran M, Ong PG, Zheng Y, Wong TY, Aung T et al (2015) Prevalence, risk factors, and visual features of undiagnosed glaucoma: the Singapore epidemiology of eye diseases study. JAMA Ophthalmol 133(8):938–946 PubMed
22.
Zurück zum Zitat Topouzis F, Coleman AL, Harris A, Koskosas A, Founti P, Gong G et al (2008) Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki eye study. Am J Ophthalmol 145(2):327–335 PubMed Topouzis F, Coleman AL, Harris A, Koskosas A, Founti P, Gong G et al (2008) Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki eye study. Am J Ophthalmol 145(2):327–335 PubMed
23.
Zurück zum Zitat Chan MPY, Broadway DC, Khawaja AP, Yip JLY, Garway-Heath DF, Burr JM et al (2017) Glaucoma and intraocular pressure in EPIC-Norfolk eye study: cross sectional study. BMJ 358:j3889 PubMedCentralPubMed Chan MPY, Broadway DC, Khawaja AP, Yip JLY, Garway-Heath DF, Burr JM et al (2017) Glaucoma and intraocular pressure in EPIC-Norfolk eye study: cross sectional study. BMJ 358:j3889 PubMedCentralPubMed
24.
Zurück zum Zitat Foster PJ, Buhrmann R, Quigley HA, Johnson GJ (2002) The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 86(2):238–242 PubMedCentralPubMed Foster PJ, Buhrmann R, Quigley HA, Johnson GJ (2002) The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 86(2):238–242 PubMedCentralPubMed
25.
Zurück zum Zitat Gupta P, Zhao D, Guallar E, Ko F, Boland MV, Friedman DS (2016) Prevalence of glaucoma in the United States: the 2005–2008 national health and nutrition examination survey. Invest Ophthalmol Vis Sci 57(6):2905–2913 PubMed Gupta P, Zhao D, Guallar E, Ko F, Boland MV, Friedman DS (2016) Prevalence of glaucoma in the United States: the 2005–2008 national health and nutrition examination survey. Invest Ophthalmol Vis Sci 57(6):2905–2913 PubMed
26.
Zurück zum Zitat Eke T, Reddy MA, Karwatowski WS (1999) Glaucoma awareness and screening uptake in relatives of people with glaucoma. Eye (Lond) 13(5):647–649 PubMed Eke T, Reddy MA, Karwatowski WS (1999) Glaucoma awareness and screening uptake in relatives of people with glaucoma. Eye (Lond) 13(5):647–649 PubMed
27.
Zurück zum Zitat Wolfs RCW, Borger PH, Ramrattan RS, Klaver CCW, Hulsman CAA, Hofman A et al (2000) Changing views on open-angle glaucoma: definitions and prevalences—the Rotterdam study. Investigative ophthalmology & visual. Science 41(11):3309–3321 Wolfs RCW, Borger PH, Ramrattan RS, Klaver CCW, Hulsman CAA, Hofman A et al (2000) Changing views on open-angle glaucoma: definitions and prevalences—the Rotterdam study. Investigative ophthalmology & visual. Science 41(11):3309–3321
28.
Zurück zum Zitat Höhn R, Kottler U, Peto T, Blettner M, Münzel T, Blankenberg S et al (2015) The ophthalmic branch of the Gutenberg health study: study design, cohort profile and self-reported diseases. PLoS ONE 10(3):e120476 PubMedCentralPubMed Höhn R, Kottler U, Peto T, Blettner M, Münzel T, Blankenberg S et al (2015) The ophthalmic branch of the Gutenberg health study: study design, cohort profile and self-reported diseases. PLoS ONE 10(3):e120476 PubMedCentralPubMed
29.
Zurück zum Zitat Stark K, Olden M, Brandl C, Dietl A, Zimmermann ME, Schelter SC et al (2015) The German AugUR study: study protocol of a prospective study to investigate chronic diseases in the elderly. BMC Geriatr 15:130 PubMedCentralPubMed Stark K, Olden M, Brandl C, Dietl A, Zimmermann ME, Schelter SC et al (2015) The German AugUR study: study protocol of a prospective study to investigate chronic diseases in the elderly. BMC Geriatr 15:130 PubMedCentralPubMed
30.
Zurück zum Zitat Steinkirchner AB, Zimmermann ME, Donhauser FJ, Dietl A, Brandl C, Koller M et al (2022) Self-report of chronic diseases in old-aged individuals: extent of agreement with general practitioner medical records in the German AugUR study. J Epidemiol Community Health 76(11):931–938 PubMed Steinkirchner AB, Zimmermann ME, Donhauser FJ, Dietl A, Brandl C, Koller M et al (2022) Self-report of chronic diseases in old-aged individuals: extent of agreement with general practitioner medical records in the German AugUR study. J Epidemiol Community Health 76(11):931–938 PubMed
31.
Zurück zum Zitat Brandl C, Zimmermann ME, Günther F, Barth T, Olden M, Schelter SC et al (2018) On the impact of different approaches to classify age-related macular degeneration: results from the German AugUR study. Sci Rep 8(1):8675 PubMedCentralPubMed Brandl C, Zimmermann ME, Günther F, Barth T, Olden M, Schelter SC et al (2018) On the impact of different approaches to classify age-related macular degeneration: results from the German AugUR study. Sci Rep 8(1):8675 PubMedCentralPubMed
32.
Zurück zum Zitat Deutsche Ophthalmolgische Gesellschaft e. V. (DOG) (2020) S2e Leitlinie: Bewertung von Risikofaktoren für das Auftreten des Offenwinkelglaukoms Deutsche Ophthalmolgische Gesellschaft e. V. (DOG) (2020) S2e Leitlinie: Bewertung von Risikofaktoren für das Auftreten des Offenwinkelglaukoms
33.
Zurück zum Zitat Aspberg J, Heijl A, Bengtsson B (2021) Screening for open-angle glaucoma and its effect on blindness. Am J Ophthalmol 228:106–116 PubMed Aspberg J, Heijl A, Bengtsson B (2021) Screening for open-angle glaucoma and its effect on blindness. Am J Ophthalmol 228:106–116 PubMed
34.
Zurück zum Zitat Aspberg J, Heijl A, Bengtsson B (2023) Estimating the length of the preclinical detectable phase for open-angle glaucoma. JAMA Ophthalmol 141(1):48–54 PubMed Aspberg J, Heijl A, Bengtsson B (2023) Estimating the length of the preclinical detectable phase for open-angle glaucoma. JAMA Ophthalmol 141(1):48–54 PubMed
35.
Zurück zum Zitat Mokhles P, Schouten JS, Beckers HJ, Azuara-Blanco A, Tuulonen A, Webers CA (2016) A systematic review of end-of-life visual impairment in open-angle glaucoma: an epidemiological autopsy. J Glaucoma 25(7):623–628 PubMed Mokhles P, Schouten JS, Beckers HJ, Azuara-Blanco A, Tuulonen A, Webers CA (2016) A systematic review of end-of-life visual impairment in open-angle glaucoma: an epidemiological autopsy. J Glaucoma 25(7):623–628 PubMed
36.
Zurück zum Zitat Chuvarayan Y, Finger RP, Köberlein-Neu J (2020) Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study. Eur J Health Econ 21(1):115–127 PubMed Chuvarayan Y, Finger RP, Köberlein-Neu J (2020) Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study. Eur J Health Econ 21(1):115–127 PubMed
37.
Zurück zum Zitat Hamid S, Desai P, Hysi P, Burr JM, Khawaja AP (2022) Population screening for glaucoma in UK: current recommendations and future directions. Eye (Lond) 36(3):504–509 PubMed Hamid S, Desai P, Hysi P, Burr JM, Khawaja AP (2022) Population screening for glaucoma in UK: current recommendations and future directions. Eye (Lond) 36(3):504–509 PubMed
38.
Zurück zum Zitat Weih LM, Nanjan M, McCarty CA, Taylor HR (2001) Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108(11):1966–1972 PubMed Weih LM, Nanjan M, McCarty CA, Taylor HR (2001) Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108(11):1966–1972 PubMed
39.
Zurück zum Zitat Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC (1994) Family history and risk of primary open angle glaucoma. The Baltimore eye survey. Arch Ophthalmol 112(1):69–73 PubMed Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC (1994) Family history and risk of primary open angle glaucoma. The Baltimore eye survey. Arch Ophthalmol 112(1):69–73 PubMed
40.
Zurück zum Zitat Craig JE, Han X, Qassim A, Hassall M, Cooke Bailey JN, Kinzy TG et al (2020) Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression. Nat Genet 52(2):160–166 PubMedCentralPubMed Craig JE, Han X, Qassim A, Hassall M, Cooke Bailey JN, Kinzy TG et al (2020) Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression. Nat Genet 52(2):160–166 PubMedCentralPubMed
41.
Zurück zum Zitat Hemelings R, Elen B, Barbosa-Breda J, Lemmens S, Meire M, Pourjavan S et al (2020) Accurate prediction of glaucoma from colour fundus images with a convolutional neural network that relies on active and transfer learning. Acta Ophthalmol 98(1):e94–e100 PubMed Hemelings R, Elen B, Barbosa-Breda J, Lemmens S, Meire M, Pourjavan S et al (2020) Accurate prediction of glaucoma from colour fundus images with a convolutional neural network that relies on active and transfer learning. Acta Ophthalmol 98(1):e94–e100 PubMed
42.
Zurück zum Zitat Hemelings R, Elen B, Schuster AK, Blaschko MB, Barbosa-Breda J, Hujanen P et al (2023) A generalizable deep learning regression model for automated glaucoma screening from fundus images. NPJ Digit Med 6(1):112 PubMedCentralPubMed Hemelings R, Elen B, Schuster AK, Blaschko MB, Barbosa-Breda J, Hujanen P et al (2023) A generalizable deep learning regression model for automated glaucoma screening from fundus images. NPJ Digit Med 6(1):112 PubMedCentralPubMed
43.
Zurück zum Zitat Wang X, Chen H, Ran AR, Luo L, Chan PP, Tham CC et al (2020) Towards multi-center glaucoma OCT image screening with semi-supervised joint structure and function multi-task learning. Med Image Anal 63:101695 PubMed Wang X, Chen H, Ran AR, Luo L, Chan PP, Tham CC et al (2020) Towards multi-center glaucoma OCT image screening with semi-supervised joint structure and function multi-task learning. Med Image Anal 63:101695 PubMed
44.
Zurück zum Zitat Brusini P (2018) OCT glaucoma staging system: a new method for retinal nerve fiber layer damage classification using spectral-domain OCT. Eye (Lond) 32(1):113–119 PubMed Brusini P (2018) OCT glaucoma staging system: a new method for retinal nerve fiber layer damage classification using spectral-domain OCT. Eye (Lond) 32(1):113–119 PubMed
45.
Zurück zum Zitat Hemelings R, Elen B, Barbosa-Breda J, Bellon E, Blaschko MB, De Boever P et al (2022) Pointwise visual field estimation from optical coherence tomography in glaucoma using deep learning. Transl Vis Sci Technol 11(8):22 PubMedCentralPubMed Hemelings R, Elen B, Barbosa-Breda J, Bellon E, Blaschko MB, De Boever P et al (2022) Pointwise visual field estimation from optical coherence tomography in glaucoma using deep learning. Transl Vis Sci Technol 11(8):22 PubMedCentralPubMed
46.
Zurück zum Zitat Jampel HD, Schwartz GF, Robin AL, Abrams DA, Johnson E, Miller RB (2003) Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol 121(4):540–546 PubMed Jampel HD, Schwartz GF, Robin AL, Abrams DA, Johnson E, Miller RB (2003) Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol 121(4):540–546 PubMed
47.
Zurück zum Zitat Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW (2003) Compliance barriers in glaucoma: a systematic classification. J Glaucoma 12(5):393–398 PubMed Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW (2003) Compliance barriers in glaucoma: a systematic classification. J Glaucoma 12(5):393–398 PubMed
48.
Zurück zum Zitat Schenker H, Maloney S, Liss C, Gormley G, Hartenbaum D (1999) Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma. Clin Ther 21(1):138–147 PubMed Schenker H, Maloney S, Liss C, Gormley G, Hartenbaum D (1999) Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma. Clin Ther 21(1):138–147 PubMed
49.
Zurück zum Zitat Kass MA, Gordon M, Morley RE Jr., Meltzer DW, Goldberg JJ (1987) Compliance with topical timolol treatment. Am J Ophthalmol 103(2):188–193 PubMed Kass MA, Gordon M, Morley RE Jr., Meltzer DW, Goldberg JJ (1987) Compliance with topical timolol treatment. Am J Ophthalmol 103(2):188–193 PubMed
50.
Zurück zum Zitat Konstas AGP, Maskaleris G, Gratsonidis S, Sardelli C (2000) Compliance and viewpoint of glaucoma patients in Greece. Eye (Lond) 14(5):752–756 PubMed Konstas AGP, Maskaleris G, Gratsonidis S, Sardelli C (2000) Compliance and viewpoint of glaucoma patients in Greece. Eye (Lond) 14(5):752–756 PubMed
51.
Zurück zum Zitat Rotchford AP, Murphy KM (1998) Compliance with timolol treatment in glaucoma. Eye (Lond) 12(2):234–236 PubMed Rotchford AP, Murphy KM (1998) Compliance with timolol treatment in glaucoma. Eye (Lond) 12(2):234–236 PubMed
52.
Zurück zum Zitat Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J (1998) Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care 36(3):357–369 PubMed Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J (1998) Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care 36(3):357–369 PubMed
53.
Zurück zum Zitat Patel SC, Spaeth GL (1995) Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 26(3):233–236 PubMed Patel SC, Spaeth GL (1995) Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 26(3):233–236 PubMed
54.
Zurück zum Zitat Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N et al (1993) Treatment for glaucoma: adherence by the elderly. Am J Public Health 83(5):711–716 PubMedCentralPubMed Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N et al (1993) Treatment for glaucoma: adherence by the elderly. Am J Public Health 83(5):711–716 PubMedCentralPubMed
55.
Zurück zum Zitat Frech S, Guthoff RF, Gamael A, Helbig C, Diener A, Ritzke M et al (2021) Patterns and facilitators for the promotion of glaucoma medication adherence—a qualitative study. Healthcare 9(4):426 PubMedCentralPubMed Frech S, Guthoff RF, Gamael A, Helbig C, Diener A, Ritzke M et al (2021) Patterns and facilitators for the promotion of glaucoma medication adherence—a qualitative study. Healthcare 9(4):426 PubMedCentralPubMed
56.
Zurück zum Zitat Frech S, Kreft D, Guthoff RF, Doblhammer G (2018) Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—an observational cohort study. PLoS ONE 13(1):e191185 PubMedCentralPubMed Frech S, Kreft D, Guthoff RF, Doblhammer G (2018) Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—an observational cohort study. PLoS ONE 13(1):e191185 PubMedCentralPubMed
57.
Zurück zum Zitat Schwartz GF, Quigley HA (2008) Adherence and persistence with glaucoma therapy. Surv Ophthalmol 53(6):S57–S68 PubMed Schwartz GF, Quigley HA (2008) Adherence and persistence with glaucoma therapy. Surv Ophthalmol 53(6):S57–S68 PubMed
58.
Zurück zum Zitat Newman-Casey PA, Weizer JS, Heisler M, Lee PP, Stein JD (2013) Systematic review of educational interventions to improve glaucoma medication adherence. Semin Ophthalmol 28(3):191–201 PubMedCentralPubMed Newman-Casey PA, Weizer JS, Heisler M, Lee PP, Stein JD (2013) Systematic review of educational interventions to improve glaucoma medication adherence. Semin Ophthalmol 28(3):191–201 PubMedCentralPubMed
59.
Zurück zum Zitat Ha A, Jang M, Shim SR, Kim CY, Chang IB, Kim YK (2022) Interventions for glaucoma medication adherence improvement: a network meta-analysis of randomized controlled trials. Ophthalmology 129(11):1294–1304 PubMed Ha A, Jang M, Shim SR, Kim CY, Chang IB, Kim YK (2022) Interventions for glaucoma medication adherence improvement: a network meta-analysis of randomized controlled trials. Ophthalmology 129(11):1294–1304 PubMed
60.
61.
Zurück zum Zitat Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y et al (2009) Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology 116(12):2286–2293 PubMed Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y et al (2009) Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology 116(12):2286–2293 PubMed
62.
Zurück zum Zitat Cook PF, Bremer RW, Ayala AJ, Kahook MY (2010) Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence. Clin Ophthalmol 4:1091–1101 PubMedCentralPubMed Cook PF, Bremer RW, Ayala AJ, Kahook MY (2010) Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence. Clin Ophthalmol 4:1091–1101 PubMedCentralPubMed
Metadaten
Titel
Bewusstsein für eine Glaukomerkrankung in der Bevölkerung
verfasst von
Dr. med. Julia V. Stingl
R. Greslechner
Caroline Brandl
Iris M. Heid
Esther M. Hoffmann
Norbert Pfeiffer
Alexander K. Schuster
Publikationsdatum
17.10.2023
Verlag
Springer Medizin
Schlagwort
Glaukom
Erschienen in
Die Ophthalmologie / Ausgabe 11/2023
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-023-01943-0

Weitere Artikel der Ausgabe 11/2023

Die Ophthalmologie 11/2023 Zur Ausgabe